A proprietary extended-release oral minoxidil, VDPHL01, shows superior efficacy and a consistent safety profile vs placebo for hair loss in men.

A safer and more effective formulation of the most popular hair-loss treatment led to robust hair growth in a clinical trial.

Company’s extended-release formulation of zinc acetate will be compared to GALZIN® (zinc acetate) and a placebo for the treatment of Wilson disease -- DEER PARK, Ill., April 27, 2026 (GLOBE NEWSWIRE)- ...

Veradermics Incorporated (NYSE:MANE) saw its stock rise 17% on Monday after announcing positive topline data from a Phase 2/3 ...

DUBLIN--(BUSINESS WIRE)--The "Extended Release Injectable Drugs" report has been added to ResearchAndMarkets.com's offering. Chronic conditions require drug administration over long periods of time, ...

FluidCrystal® extended release formulation of zilucoplan achieved rapid and sustained pharmacodynamic inhibition of complement C5 in non-human primates, supporting at least once weekly dosing ...

Please provide your email address to receive an email when new articles are posted on . The majority of patients receiving opioid analgesics used immediate-release formulations, regardless of the ...

WOODCLIFF LAKE, N.J. and SAN DIEGO, Nov. 30, 2015 /PRNewswire/ -- Eisai Inc. and Arena Pharmaceuticals, Inc. (ARNA) today announced that the U.S. Food and Drug Administration (FDA) has accepted for ...

Phase I pharmacokinetic study of single agent trametinib in advanced cancer patients with hepatic dysfunction: An NCI Organ Dysfunction Working Group (ODWG) study. Investigational NEDD8-activating ...

WOODCLIFF LAKE, N.J. and SAN DIEGO, Calif., April 10, 2015 /PRNewswire/ -- Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced the completion of two Phase 1 registrational ...

The FDA approved an oral extended-release formulation of levodopa and carbidopa known as IPX203 (Crexont) to treat Parkinson's disease, Amneal Pharmaceuticals announced Wednesday. The treatment is a ...